Serial estimates of serum permeability activity and clinical correlates in patients with native kidney focal segmental glomerulosclerosis

Journal of the American Society of Nephrology

Volumn 14, Issue 2, 2003, Pages 448-453

  Cattran, Daniel ^a,b   Neogi, Tuhina ^a   Sharma, Ram ^a   McCarthy, Ellen T ^a   Savin, Virginia J ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANGIOTENSIN RECEPTOR ANTAGONIST; CREATININE; CYCLOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PLACEBO; PLASMA PROTEIN; PREDNISONE; PROTEIN PALB; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CELL MEMBRANE PERMEABILITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE CLEARANCE; FEMALE; FOCAL GLOMERULONEPHRITIS; GLOMERULUS FILTRATION; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; RISK ASSESSMENT;

EID: 0037305175     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ASN.0000046960.57614.17     Document Type: Article

References (48)

1. US Renal Data System. USRDS: 1995 Annual Data Report, Bethesda, The National Institute of Health, National Institute of Diabetes and Digestive and Kidney Disease. 1995
2. US Renal Data System. USRDS: 1997 Annual Data Report, Bethesda, The National Institute of Health, National Institute of Diabetes and Digestive and Kidney Disease, 1997
3. Rich, AR: A hitherto undescribed vulnerability of the juxtamedullary glomeruli in lipoid nephrosis. Bull John Hopkins Hospital 100: 173-187, 1957
4. Miyata J, Takebayashi S, Taguchi T, Naito S, Harada T: Evaluation and correlation of clinical and histological features of focal segmental glomerulosclerosis. Nephron 44: 115-120, 1986
5. Schwartz MM, Korbet SM, Rydell J, Borok R, Genchi R: Primary focal segmental glomerular sclerosis in adults: Prognostic value of histologic variants. Am J Kidney Dis 25: 845-852, 1995
6. Schwartz MM, Korbet SM: Primary focal segmental glomerulosclerosis: Pathology, histological variants, and pathogenesis. Am J Kidney Dis 22: 874-883, 1993
7. D'Agati V: The many masks of focal segmental glomerulosclerosis. Kidney Int 46: 1223-1241, 1994
8. Beaufils H, Alphonse JC, Guedon J, Legrain M: Focal glomerulosclerosis: Natural history and treatment. A report of 70 cases. Nephron 21: 75-85, 1978
9. Cameron JS, Turner DR, Ogg CS, Chantler C, Williams DG: The long-term prognosis of patients with focal segmental glomerulosclerosis. Clin Nephrol. 10: 213-218, 1978
10. Rydel JJ, Korbet SM, Borok RZ, Schwartz MM: Focal segmental glomerular sclerosis in adults: Presentation, course, and response to treatment. Am J Kidney Dis 25: 534-542, 1995
11. Mongeau JG, Robitaille PO, Clermont MJ, Merouani A, Russo P: Focal segmental glomerulosclerosis (FSG) 20 years later. From toddler to grown up. Clin Nephrol. 40: 1-6, 1993
12. Banfi G, Moriggi M, Sabadini E, Fellin G, D'Amico G, Ponticelli C: The impact of prolonged immunosuppression on the outcome of idiopathic focal-segmental glomerulosclerosis with nephrotic syndrome in adults. A collaborative retrospective study. Clin Nephrol 36: 53-59, 1991
13. Brodehl J, Brodehl J, Helmchen U, Hoyer PI, Burghard R, Ehrich JH, Zimmerhackl RB, Klein W, and Wonigeit K: Cyclosporin A treatment in children with minimal change nephrotic syndrome and focal segmental glomerulosclerosis. Klin Wochenschr 66: 1126-1137, 1988
14. Burgess E: Management of focal segmental glomerulosclerosis: Evidence-based recommendations. Kidney Int Suppl 70: S26-S32, 1999
15. Ingulli E, Singh A, Baqi N, Ahmad H, Moazami S, Tejani A: Aggressive, long-term cyclosporine therapy for steroid-resistant focal segmental glomerulosclerosis. J Am Soc Nephrol 5:1820-1825, 1995
16. Lieberman KV, Tejani A: A randomized double-blind placebo-controlled trial of cyclosporine in steroid-resistant idiopathic focal segmental glomerulosclerosis in children. J Am Soc Nephrol 7: 56-63, 1996
17. Meyrier A, Condamin MC, Broneer D: Treatment of adult idiopathic nephrotic syndrome with cyclosporin A: Minimal-change disease and focal-segmental glomerulosclerosis. Collaborative Group of the French Society of Nephrology. Clin Nephrol. 35[Suppl 1]: S37-S42, 1991
18. Nagai R, Cattran DC, Pei Y: Steroid therapy and prognosis of focal segmental glomerulosclerosis in the elderly. Clin Nephrol 42: 18-21, 1994
19. Pei Y, Cattran D, Delmore T, Katz A, Lang A, Rance P: Evidence suggesting under-treatment in adults with idiopathic focal segmental glomerulosclerosis. Regional Glomerulonephritis Registry Study. Am J Med 82: 938-944, 1987
20. Ponticelli C, Rizzoni G, Edefonti A, Altieri P, Rivolta E, Rinaldi S, Ghio L, Lusvarghi E, Gusmano R, Locatelli F: A randomized trial of cyclosporine in steroid-resistant idiopathic nephrotic syndrome. Kidney Int 43: 1377-1384, 1993
21. Ponticelli C, Edefonti A, Ghio L, Rizzoni G, Rinaldi S, Gusmano R, Lama G, Zacchello G, Confalonieri R, Altieri P: Cyclosporin versus cyclophosphamide for patients with steroid-dependent and frequently relapsing idiopathic nephrotic syndrome: A multicentre randomized controlled trial. Nephrol Dial Transplant 8: 1326-1332, 1993
22. Tarshish P, Tobin JN, Bernstein J, Edelmann CM, Jr: Cyclophosphamide does not benefit patients with focal segmental glomerulosclerosis. A report of the International Study of Kidney Disease in Children. Pediatr Nephrol 10: 590-593, 1996
23. Walker RG, Kincaid-Smith P: The effect of treatment of corticosteroid-resistant idiopathic (primary) focal and segmental hyalinosis and sclerosis (focal glomerulosclerosis) with ciclosporin. Nephron 54: 117-121, 1990
24. Cattran DC, Appel GB, Hebert LA, Hunsicker LG, Pohl MA, Hoy WE, Maxwell DR, Kunis CL: A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis. North America Nephrotic Syndrome Study Group. Kidney Int 56: 2220-2226, 1999
25. Cattran DC, Rao P: Long-term outcome in children and adults with classic focal segmental glomerulosclerosis. Am J Kidney Dis 32: 72-79, 1998
26. Hoyer JR, Vernier RL, Najarian JS, Raij L, Simmons RL, Michael AF: Recurrence of idiopathic nephrotic syndrome after renal transplantation. Lancet 2: 343-348, 1972
27. Artero M, Biava C, Amend W, Tomlanovich S, Vincenti F: Recurrent focal glomerulosclerosis: natural history and response to therapy. Am J Med 92: 375-383, 1992
28. Senggutuvan P, Cameron JS, Hartley RB, Rigden S, Chantler C, Haycock G, Williams DG, Ogg C, Koffman G: Recurrence of focal segmental glomerulosclerosis in transplanted kidneys: Analysis of incidence and risk factors in 59 allografts. Pediatr Nephrol 4: 21-28, 1990
29. Cochat P, Kassir A, Colon S, Glastre C, Tourniaire B, Parchoux B, Martin X, David L: Recurrent nephrotic syndrome after transplantation: early treatment with plasmapheresis and cyclophosphamide. Pediatr Nephrol 7: 50-54, 1993
30. Artero ML, Sharma R, Savin VJ, Vincenti F: Plasmapheresis reduces proteinuria and serum capacity to injure glomeruli in patients with recurrent focal glomerulosclerosis. Am J Kidney Dis 23: 574-581, 1994
31. Dantal J, Bigot E, Bogers W, Testa A, Kriaa F, Jacques Y, Hurault dL, Niaudet P, Charpentier B, Soulillou JP: Effect of plasma protein adsorption on protein excretion in kidney-transplant recipients with recurrent nephrotic syndrome. N Engl J Med 330: 7-14, 1994
32. Laufer J, Ettenger RB, Ho WG, Cohen AH, Marik JL, Fine RN: Plasma exchange for recurrent nephrotic syndrome following renal transplantation. Transplantation 46: 540-542, 1988
33. Savin VJ, Sharma R, Lovell HB, Welling DJ: Measurement of albumin reflection coefficient with isolated rat glomeruli. J Am Soc Nephrol 3: 1260-1269, 1992
34. Godfrin Y, Dantal J, Perretto S, Hristea D, Legendre C, Kreis H, Soulillou JP: Study of the in vitro effect on glomerular albumin permselectivity of serum before and after renal transplantation in focal segmental glomerulosclerosis. Transplantation 64: 1711-1715, 1997
35. Savin VJ, Sharma R, Sharma M, McCarthy ET, Swan SK, Ellis E, Lovell H, Warady B, Gunwar S, Chonko AM, Artero M, Vincenti F: Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis. N Engl J Med 334: 878-883, 1996
36. Sharma R, Sharma M, Ge X, McCarthy ET, Savin VJ: Cyclosporine protects glomeruli from FSGS factor via an increase in glomerular cAMP. Transplantation 62: 1916-1920, 1996
37. Sharma R, Savin VJ: Cyclosporine prevents the increase in glomerular albumin permeability caused by serum from patients with focal segmental glomerular sclerosis. Transplantation 61: 381-383, 1996
38. Feld SM, Figueroa P, Savin V, Nast CC, Sharma R, Sharma M, Hirschberg R, Adler SG: Plasmapheresis in the treatment of steroid-resistant focal segmental glomerulosclerosis in native kidneys. Am J Kidney Dis 32: 230-237, 1998
39. Kemper MJ, Wolf G, Muller-Wiefel DE: Transmission of glomerular permeability factor from a mother to her child. N Engl J Med 344: 386-387, 2001
40. Zimmerman SW: Increased urinary protein excretion in the rat produced by serum from a patient with recurrent focal glomerular sclerosis after renal transplantation. Clin Nephrol 22: 32-38, 1984
41. Sharma M, Sharma R, McCarthy ET, Savin VJ: "The FSGS factor:" enrichment and in vivo effect of activity from focal segmental glomerulosclerosis plasma. J Am Soc Nephrol 10: 552-561, 1999
42. Trachtman H, Futterweit S, Singhal PC, Franki N, Sharma M, Sharma R, Savin V: Circulating factor in patients with recurrent focal segmental glomerulosclerosis postrenal transplantation inhibits expression of inducible nitric oxide synthase and nitric oxide production by cultured rat mesangial cells. J Investig Med 47: 114-120, 1999
43. Sharma R, Khanna AK, Sharma M, Savin VJ: Transforming growth factor increases glomerular albumin permeability via hydroxyl radicals. Kidney Int 58: 131-136, 2000
44. McCarthy ET, Sharma M: Indomethacin protects permeability barrier from focal segmental glomerulosclerosis serum. Kidney Int 61: 534-541, 2002
45. Sharma RD, Sharma M, McCarthy ET, Ge XL, Savin V: Components of normal serum block the focal segmental glomerulosclerosis factor activity in vitro. Kidney Int 58: 1973-1079, 2000
46. Carraro M, Caridi G, Bruschi M, Artero M, Bertelli R, Zennaro C, Musante L, Candiano G, Perfumo Francesco, Ghiggeri GM: Serum glomerular permeability activity in patients with podocin mutations (NPHS2) and steroid resistant nephrotic syndrome. J Am Soc Nephrol 13: 1046-1052, 2002
47. Kriz W: Progressive renal failure - Inability of podocytes to replicate and the consequences for development of glomerulosclerosis. Nephrol Dial Transplant 11: 1738-1742, 1996
48. Diamond JR, Karnovsky MJ: Focal and segmental glomerulosclerosis: Analogies to atherosclerosis. Kidney Int 33: 917-924, 1988